
AKIPRESS.COM - 16.7 billion soums ($1.4 million) have been paid to victims of Doc-1 Max syrup poisoning in Uzbekistan. The total compensation awarded by court rulings stands at 78 billion soums ($6.5 million), Daryo reported, citing Uzbekistan's Bureau of Compulsory Enforcement.
The Bureau issued this statement in response to reports that victims of Doc-1 Max poisoning were not receiving compensation. A group of parents sent an appeal to the President of Uzbekistan, requesting the full enforcement of court rulings on these payments, in October 2025.
The Bureau noted that the enforcement proceedings concern the recovery of damages for 85 citizens from the debtor (former director of the Pharmaceutical Industry Development Agency Sardor Kariev) and other individuals.
As part of the recovery process, real estate properties in Tashkent owned by Kariev were seized and put up for online auction. Specifically, a non-residential building on Furkat Street was sold for 793 million soums ($66,000). Residential properties on Katortol Street, valued at 7.1 billion soums ($591,000), have not yet been sold. Auctions for them are ongoing.
Payments to the victims were made using funds from auction sales as well as amounts contributed by Kariev's family members. These funds were distributed equally among the claimants.
The mass poisoning of children involving Doc-1 Max syrup, manufactured by the Indian company Marion Biotech, occurred in late 2022. The toxic substance ethylene glycol was detected in the syrup. According to official figures, 69 children died, and another 16 were left with disabilities. The Tashkent city court handed down sentences to 23 defendants in the case in February 2024. Indian national and executive of the distributor Quramax Medical Raghvendra Pratar was sentenced to 20 years in prison, former director of the Pharmaceutical Industry Development Agency Sardor Kariev received an 18-year sentence, and his deputies were sentenced to 16 years each.
The court also ordered several of the convicted individuals to pay compensation to the victims. The amounts set were 1 billion soums ($83,000) for each of the 68 fatalities and four cases of severe health consequences, 500 million soums ($41,600) for the families of four children whose condition was satisfactory, and 200 million soums ($16,600) for eight children who recovered.
In May 2024, mother of the former Pharmaceutical Agency director Munira Karieva announced her willingness to pay 75.6 billion soums ($6 million) to the relatives of the deceased and injured children in exchange for her son's release over three years. She deposited 2.5 billion soums ($200,000) into the court's escrow account. However, in July, the appellate court upheld the original verdict and ordered that the funds deposited by Karieva be distributed equally among the legal representatives of the deceased and injured children.
